Incannex Healthcare (ASX: IHL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Incannex Healthcare Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Incannex Healthcare (ASX: IHL)
Latest News
Cannabis Shares
Could ASX cannabis shares be set for a resurgence?
Healthcare Shares
Incannex share price races higher on 'pivotal' trial approval
Share Fallers
Why Incannex, Magellan, Nexted, and Strandline shares are dropping today
Healthcare Shares
Why you soon won't be able to find Incannex shares on the ASX
Cannabis Shares
Why ASX cannabis shares just jumped back into the spotlight
Cannabis Shares
Should I buy Incannex shares while they're at multi-year lows, or steer clear?
Cannabis Shares
A $3k investment in ASX cannabis stock Incannex 5 years ago is now worth $15,000. Here's why
Share Gainers
2 ASX All Ordinaries stocks leaping higher following strong quarters
Healthcare Shares
ASX 300 cannabis stock Incannex suspended ahead of 'material update'
Cannabis Shares
Buying ASX cannabis stocks? Here's what the Victorian government is considering right now
Cannabis Shares
Why did this ASX 300 cannabis share just rocket 12%?
Share Gainers
2 ASX All Ords shares going gangbusters on Monday
Frequently Asked Questions
-
Incannex listed on the ASX in May 2007.
-
No, Incannex has not yet paid out any dividends.
IHL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Incannex Healthcare
Incannex Healthcare Ltd (ASX: IHL) is a developer of cannabinoid and psychedelic compound medicines. It is currently involved in clinical programs for the treatment of six conditions: Obstructive Sleep Apnea (OSA), Generalised Anxiety Disorder (GAD), traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions.
The company has an Australian license to import, export, and distribute medicinal cannabis products and has a line of cannabinoid products.